Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Amin, O. Kucuk, F. Khuri, D. Shin (2009)
Perspectives for cancer prevention with natural compounds.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 16
K. Danø, P. Andreasen, J. Grøndahl-Hansen, Peter Kristensen, L. Nielsen, L. Skriver (1985)
Plasminogen activators, tissue degradation, and cancer.Advances in cancer research, 44
M. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, M. Rath (2005)
In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7Medical Oncology, 22
J. Pellikainen, K. Ropponen, V. Kataja, J. Kellokoski, M. Eskelinen, V. Kosma (2004)
Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and PrognosisClinical Cancer Research, 10
M. Sugimura, H. Kobayashi, N. Kanayama, T. Terao (1992)
Clinical significance of urokinase-type plasminogen activator (uPA) in invasive cervical cancer of the uterus.Gynecologic oncology, 46 3
A. Chambers, L. Matrisian (1997)
Changing views of the role of matrix metalloproteinases in metastasis.Journal of the National Cancer Institute, 89 17
William Stetler-Stevenson (2001)
The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.Surgical oncology clinics of North America, 10 2
Global cancer statistics Breastcancer . org : U . S . Breast Cancer Statistics
川上 理 (2001)
Inhibitory effects of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells
Guang-Yu Yang, J. Liao, Kyounghyun Kim, E. Yurkow, Chung Yang (1998)
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.Carcinogenesis, 19 4
W. Kuhn, L. Pache, B. Schmalfeldt, P. Dettmar, Manfred Schmitt, Fritz Jänicke, Henner Graeff (1994)
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.Gynecologic oncology, 55 3 Pt 1
(1997)
Molecular biology of cancer : invasion and metastasis
W. Bidlack (2001)
Green Tea: Health Benefits and Applications.Journal of the American College of Nutrition, 20
D. Alonso, E. Farias, V. Ladeda, L. Davel, L. Puricelli, E. Joffé (2005)
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor modelBreast Cancer Research and Treatment, 40
M. Egeblad, Z. Werb (2002)
New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2
Qi Chen, M. Espey, M. Krishna, James Mitchell, C. Corpe, G. Buettner, E. Shacter, M. Levine (2005)
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.Proceedings of the National Academy of Sciences of the United States of America, 102 38
C. Maramag, M. Menon, K. Balaji, Premveer Reddy, S. Laxmanan (1997)
Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesisThe Prostate, 32
G. Steele (1983)
Cancer: Principles and Practice of OncologyArchives of Surgery, 118
K. Naidu, R. Karl, K. Naidu, D. Coppola (2004)
Antiproliferative and Proapoptotic Effect of Ascorbyl Stearate in Human Pancreatic Cancer Cells: Association with Decreased Expression of Insulin-Like Growth Factor 1 ReceptorDigestive Diseases and Sciences, 48
H. Anthony, C. Schorah (1982)
Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance.British Journal of Cancer, 46
(2001)
Inhibitory effects of selenite on invasion of HT 1080 tumor cells
(2011)
Ovarian Cancer National Alliance: Ovarian Cancer Statistics. http://www.ovariancancer.org/about-ovarian-cancer/statsitics
A. Scorilas, A. Karameris, N. Arnogiannaki, A. Ardavanis, P. Bassilopoulos, T. Trangas, M. Talieri (2001)
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatientsBritish Journal of Cancer, 84
H. Mukhtar, N. Ahmad (2000)
Tea polyphenols: prevention of cancer and optimizing health.The American journal of clinical nutrition, 71 6 Suppl
P. Yurchenco, J. Schittny (1990)
Molecular architecture of basement membranesThe FASEB Journal, 4
Ovarian Cancer National Alliance: Ovarian Cancer Statistics
Eric Steiner, Kunhard Pollow, Dirk Hasenclever, W. Schormann, M. Hermes, Marcus Schmidt, A. Puhl, M. Brulport, A. Bauer, I. Petry, Heinz Koelbl, Jan Hengstler (2008)
Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.Gynecologic oncology, 108 3
B. Bachmeier, A. Nerlich, R. Lichtinghagen, C. Sommerhoff (2001)
Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.Anticancer research, 21 6A
Sang-Oh Yoon, Moon‐Moo Kim, A. Chung (2001)
Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells*The Journal of Biological Chemistry, 276
(1998)
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis
(2012)
Uterine) Cancer: What are the key statistics about endometrial cancer? http://www.cancer.org/Cancer/Endometrial Cancer/DetailedGuide/endometrial-uterine-cancer-key-statistics
D. Sato, M. Matsushima (2003)
Preventive effects of urinary bladder tumors induced by N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine in rat by green tea leavesInternational Journal of Urology, 10
Endometrial ( Uterine ) Cancer : What are the key statistics about endometrial cancer ?
K. Aglund, M. Rauvala, U. Puistola, T. Ångström, T. Turpeenniemi‐Hujanen, B. Zackrisson, U. Stendahl (2004)
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.Gynecologic oncology, 94 3
C. Martín, A. Ruiz (1995)
[Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of the consumption of food with an elevated content of this vitamin].Nutricion hospitalaria, 10 6
Effect of vitamin C on
J. Kemberling, JAMES Hampton, R. Keck, MICHAEL Gomez, S. Selman (2003)
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.The Journal of urology, 170 3
(1997)
cancer cells in vitro : effect on cell number , viability and DNA synthesis
(2011)
Global cancer statistics. CA Cancer J Clin
Ziyong Sun, Yu-hong Chen, Ping Wang, Jing Zhang, V. Gurewich, Pei-xiang Zhang, Jian-ning Liu (2002)
The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.Biochimica et biophysica acta, 1596 2
Woo Koh, Sook-Ja Lee, Hyunah Lee, Chaehwa Park, M. Park, Won Kim, Seong-Myeong Yoon, Keunchil Park, Sun-Gi Hong, Mi-Ja Chung, Chan Park (1998)
Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.Anticancer research, 18 4A
S. Barsky, G. Siegal, F. Jannotta, L. Liotta (1983)
Loss of basement membrane components by invasive tumors but not by their benign counterparts.Laboratory investigation; a journal of technical methods and pathology, 49 2
(2003)
Serum markers of the liver, heart, and kidney and lipid profile and histopathology in ODS rats treated with nutrient synergy
P. Torng, T. Mao, W. Chan, Su‐cheng Huang, Chin-Tang Lin (2004)
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.Gynecologic oncology, 92 2
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)
Global Cancer Statistics
S. Memarzadeh, Katherine Kozak, L. Chang, S. Natarajan, P. Shintaku, S. Reddy, R. Farias-Eisner (2002)
Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancerProceedings of the National Academy of Sciences of the United States of America, 99
(2002)
Expression of matrix metallo- proteinase-2,9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix
Cai-yun Zhou, Ji-fen Yao, Xiao-duan Chen (2002)
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].Ai zheng = Aizheng = Chinese journal of cancer, 21 7
L. Liotta, K. Tryggvason, S. Garbisa, I. Hart, C. Foltz, S. Shafie (1980)
Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 284
M. Bérubé, A. Deschambeault, M. Boucher, L. Germain, E. Petitclerc, S. Guérin (2005)
MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.Molecular vision, 11
M. Morini, T. Cai, M. Aluigi, D. Noonan, L. Masiello, S. Flora, Francesco D'Agostini, A. Albini, G. Fassina (1999)
The Role of the Thiol N-Acetylcysteine in the Prevention of Tumor Invasion and AngiogenesisThe International Journal of Biological Markers, 14
S. Kawakami, Y. Kageyama, Y. Fujii, K. Kihara, H. Oshima (2001)
Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells.Anticancer research, 21 1A
C. Kurbacher, Uwe Wagner, Bernd Kolster, P. Andreotti, Dieter Krebs, Howard Bruckner (1996)
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro.Cancer letters, 103 2
S. Valcic, B. Timmermann, D. Alberts, G. Wächter, M. Krutzsch, J. Wymer, J. Guillen (1996)
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell linesAnti-Cancer Drugs, 7
(1996)
Effects of synthetic urokinase on local invasion and metastasis in a murine mammary tumor model
W. Stetler-Stevenson (1990)
Type IV collagenases in tumor invasion and metastasisCancer and Metastasis Reviews, 9
(2011)
Breastcancer.org: U.S. Breast Cancer Statistics
M. Duffy, C. Duggan, H. Mulcahy, E. McDermott, N. O’higgins (1998)
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease.Clinical chemistry, 44 6 Pt 1
Suhail Ali, H. Harvey, A. Lipton (2003)
Metastatic breast cancer: overview of treatment.Clinical orthopaedics and related research, 415 Suppl
A. Nelson, B. Fingleton, M. Rothenberg, L. Matrisian (2000)
Matrix metalloproteinases: biologic activity and clinical implications.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 5
M. Rath, L. Pauling (2007)
Plasmin-Induced Proteolysis and the Role of Apoprotein ( a ) , Lysine , and Synthetic Lysine Analogs
(1998)
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary nodenegative disease
A. Lopata, F. Agresta, M. Quinn, Catherine Smith, A. Ostor, L. Salamonsen (2003)
Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity.Gynecologic oncology, 90 2
John Cooke, V. Dzau (1997)
Nitric oxide synthase: role in the genesis of vascular disease.Annual review of medicine, 48
M. Roomi, J. Monterrey, T. Kalinovsky, M. Rath, A. Niedzwiecki (2010)
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.Oncology reports, 24 3
S. Nair, D. Karunagaran, M. Nair, P. Sudhakaran (2003)
Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervixJournal of Cancer Research and Clinical Oncology, 129
(2004)
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER-2, and prognosis
J. Folkman (2002)
Role of angiogenesis in tumor growth and metastasis.Seminars in oncology, 29 6 Suppl 16
P. Andreasen, L. Kjøller, L. Christensen, M. Duffy (1997)
The urokinase‐type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 72
S. Taniguchi, H. Fujiki, H. Kobayashi, Hiroki Go, Kenji Miyado, H. Sadano, R. Shimokawa (1992)
Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines.Cancer letters, 65 1
Roomi Mw, J. Monterrey, T. Kalinovsky, M. Rath, A. Niedzwiecki (2010)
Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study.Experimental oncology, 32 4
A. Niedzwiecki, M. Roomi, T. Kalinovsky, M. Rath (2010)
Micronutrient synergy—a new tool in effective control of metastasis and other key mechanisms of cancerCancer Metastasis Reviews, 29
G. Garzetti, Andrea Ciavattini, G. Lucarini, Gaia Goteri, M. Nictolis, Spiridione Garbisa, Laura Masiero, Carlo Romanini, B. Graziella (1995)
Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.Anticancer research, 15 6B
D. Kleiner, W. Stetler-Stevenson (1999)
Matrix metalloproteinases and metastasisCancer Chemotherapy and Pharmacology, 43
Uterine) Cancer: What are the key statistics
Cancers of the breast, cervix, uterus and ovary are the most prevalent cancers in women worldwide. Proteases play a key role in tumor cell invasion and metastasis by digesting the basement membrane and ECM components. Strong clinical and experimental evidence demonstrates association of elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) with cancer progression, metastasis and shortened patient survival. MMP activities are regulated by specific tissue inhibitors of metalloproteinases (TIMPs). Our main objective was to study the effect of a nutrient mixture (NM) on the activity of u-PA, MMPs and TIMPs in human breast, cervix, uterine and ovarian cancer cell lines. Human breast (MDA-MB-231 and MCF-7), cervical (HeLa), uterine (SK-UT-1) and ovarian (SKOV3) cancer cell lines were cultured in their respective media and treated at confluence with NM at 0, 50, 100, 250, 500 and 1000 µg/ml. Analysis of u-PA activity was carried out by fibrin zymography, MMPs by gelatinase zymography and TIMPs by reverse zymography. Both breast and uterine cancer cell lines expressed u-PA, which was inhibited by NM in a dose-dependent manner. However, no bands corresponding to u-PA were detected for HeLa and SK-OV-3 cell lines. On gelatinase zymography, MDA-MB-231 and MCF-7 showed one band corresponding to MMP-9, HeLa showed two bands, an intense band corresponding to MMP-2 and a faint band corresponding to MMP-9, SK-UT-1 showed PMA-induced MMP-9, and SK-OV-3 showed a band corresponding to MMP-2. NM inhibited their expression in all cell lines. The activity of TIMPs was upregulated in all cancer cell lines in a dose-dependent manner. Analysis revealed a positive correlation between u-PA and MMPs and a negative correlation between u-PA/MMPs and TIMPs. These findings suggest the therapeutic potential of NM in the treatment of female cancers.
Oncology Reports – Spandidos Publications
Published: Sep 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.